Clorox Co stock reached a new 52-week low, closing at 110.52 USD, now trading 35.6% below its 52-week high of 171.37 USD. This marks a significant downturn for the company, as its stock has ...

Moderna (MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...

A stunning new study offers early evidence that Covid-19 vaccines might have a secret superpower: a precisely timed mRNA shot ...

Moderna is down 35.3% since the beginning of the year, and at $27.16 per share, it is trading 50.3% below its 52-week high of ...

Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.

Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

This Nasdaq biotech in my Stocks and Shares ISA portfolio just got a shot in the arm. Here's why I'm almost past caring at this point. The post Up 14% yesterday, is it the end for this train wreck in ...

Durban-headquartered pharmaceutical major Aspen Pharmacare confirmed in a Sens announcement on Friday that it has reached a ...

The democratization of investing started with discount brokers slashing commissions and advanced through no-transaction-fee ...

Major stock indexes rose Thursday, as investors digested the latest batch of corporate earnings and China trade news.

Arcturus Therapeutics Holdings Inc. faces a solid cash runway into 2028, pipeline setbacks, and risk/reward profile. Learn ...

After entering into a definitive agreement to acquire CureVac—who focuses on mRNA-based medicines for oncology and infectious ...